Silo Pharma Announces 1-for-15 Reverse Stock Split
TipRanks (Mon, 1-Jun 9:58 AM ET)
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
Globe Newswire (Thu, 7-May 8:05 AM ET)
Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
Globe Newswire (Wed, 29-Apr 9:08 AM ET)
Globe Newswire (Wed, 22-Apr 4:15 PM ET)
Silo Pharma’s PTSD Program Gains Momentum Amid Federal Push for Psychedelic Therapies
Market Chameleon (Mon, 20-Apr 7:45 AM ET)
Globe Newswire (Mon, 20-Apr 6:34 AM ET)
Market Chameleon (Tue, 7-Apr 5:53 AM ET)
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
Globe Newswire (Mon, 6-Apr 4:15 PM ET)
Market Chameleon (Tue, 23-Sep 5:56 AM ET)
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Silo Pharma trades on the NASDAQ stock market under the symbol SILO.
As of June 1, 2026, SILO stock price declined to $0.33 with 1,198,832 million shares trading.
SILO has a beta of 2.73, meaning it tends to be more sensitive to market movements. SILO has a correlation of 0.18 to the broad based SPY ETF.
SILO has a market cap of $5.41 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SILO traded as high as $4.50 and as low as $.22.
The top ETF exchange traded funds that SILO belongs to (by Net Assets): PSIL, VXF.
SILO has underperformed the market in the last year with a price return of -29.6% while the SPY ETF gained +29.8%. SILO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.2% and -16.9%, respectively, while the SPY returned +10.8% and +2.6%, respectively.
SILO support price is $.40 and resistance is $.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SILO shares will trade within this expected range on the day.
